Aflac Incorporated (NYSE:AFL) Shares Bought by Candriam S.C.A.

Candriam S.C.A. grew its position in shares of Aflac Incorporated (NYSE:AFLFree Report) by 17.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 42,984 shares of the financial services provider’s stock after purchasing an additional 6,495 shares during the quarter. Candriam S.C.A.’s holdings in Aflac were worth $4,446,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Private Trust Co. NA boosted its holdings in shares of Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock valued at $791,000 after acquiring an additional 99 shares during the period. Phillips Wealth Planners LLC boosted its holdings in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after acquiring an additional 100 shares during the period. Raleigh Capital Management Inc. boosted its holdings in shares of Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 100 shares during the period. TKG Advisors LLC boosted its holdings in shares of Aflac by 0.5% during the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after acquiring an additional 103 shares during the period. Finally, Covestor Ltd boosted its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after acquiring an additional 107 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Price Performance

Shares of Aflac stock opened at $108.48 on Friday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The company’s 50-day moving average price is $105.08 and its two-hundred day moving average price is $107.72. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The stock has a market cap of $59.29 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFLGet Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, sell-side analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Evercore ISI reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. BMO Capital Markets assumed coverage on shares of Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective for the company. Piper Sandler reduced their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Finally, Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Wednesday, February 19th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $103.36.

View Our Latest Research Report on Aflac

Insiders Place Their Bets

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.